Literature DB >> 29288429

Drug discovery, development and delivery in Alzheimer's disease.

Davide Brambilla1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29288429     DOI： 10.1007/s11095-017-2329-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  15 in total

1.  Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank.

Authors:  Warren W Barker; Cheryl A Luis; Alice Kashuba; Mercy Luis; Dylan G Harwood; David Loewenstein; Carol Waters; Pat Jimison; Eugene Shepherd; Steven Sevush; Neil Graff-Radford; Douglas Newland; Murray Todd; Bayard Miller; Michael Gold; Kenneth Heilman; Leilani Doty; Ira Goodman; Bruce Robinson; Gary Pearl; Dennis Dickson; Ranjan Duara
Journal:  Alzheimer Dis Assoc Disord       Date:  2002 Oct-Dec       Impact factor: 2.703

Review 2.  Alzheimer's disease.

Authors:  Clive Ballard; Serge Gauthier; Anne Corbett; Carol Brayne; Dag Aarsland; Emma Jones
Journal:  Lancet       Date:  2011-03-01       Impact factor: 79.321

Review 3.  Three dimensions of the amyloid hypothesis: time, space and 'wingmen'.

Authors:  Erik S Musiek; David M Holtzman
Journal:  Nat Neurosci       Date:  2015-06       Impact factor: 24.884

Review 4.  Alzheimer's disease.

Authors:  Philip Scheltens; Kaj Blennow; Monique M B Breteler; Bart de Strooper; Giovanni B Frisoni; Stephen Salloway; Wiesje Maria Van der Flier
Journal:  Lancet       Date:  2016-02-24       Impact factor: 79.321

5.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

Review 6.  Biomarkers in the diagnosis and management of Alzheimer's disease.

Authors:  Richard Wurtman
Journal:  Metabolism       Date:  2014-10-30       Impact factor: 8.694

7.  2013 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2013-03       Impact factor: 21.566

8.  The discovery of Alzheimer's disease.

Authors:  Hanns Hippius; Gabriele Neundörfer
Journal:  Dialogues Clin Neurosci       Date:  2003-03       Impact factor: 5.986

Review 9.  Drug candidates in clinical trials for Alzheimer's disease.

Authors:  Shih-Ya Hung; Wen-Mei Fu
Journal:  J Biomed Sci       Date:  2017-07-19       Impact factor: 8.410

Review 10.  Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes.

Authors:  Jeffrey Cummings
Journal:  Clin Transl Sci       Date:  2017-08-02       Impact factor: 4.689
View more
  3 in total

1.  Quercetin enrich diet during the early-middle not middle-late stage of alzheimer's disease ameliorates cognitive dysfunction.

Authors:  Yaqin Lu; Qi Liu; Qin Yu
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

2.  Anthraquinone Derivative Reduces Tau Oligomer Progression by Inhibiting Cysteine-Cysteine Interaction.

Authors:  Carlos Areche; Francisca Zapata; Mathias González; Esteban Díaz; Rubén Montecinos; Marcos Hernández; Francisco Melo; Alberto Cornejo
Journal:  ChemistryOpen       Date:  2019-02-08       Impact factor: 2.911

3.  Antiallergic drug desloratadine as a selective antagonist of 5HT2A receptor ameliorates pathology of Alzheimer's disease model mice by improving microglial dysfunction.

Authors:  Jian Lu; Chuzhao Zhang; Jianlu Lv; Xialin Zhu; Xingwu Jiang; Weiqiang Lu; Yin Lu; Zongxiang Tang; Jiaying Wang; Xu Shen
Journal:  Aging Cell       Date:  2020-12-24       Impact factor: 9.304
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.